Intelligence Platform
Patents
Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11931402
Compositions for treating heart disease by inhibiting the action of mAKAP-Ξ²
granted patentUS 11931343
CD73 inhibitors
granted patentUS 11925629
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted patentUS 11926826
Twist signaling inhibitor compositions and methods of using the same
granted patentUS 11919880
HCV protease inhibitors
granted patentUS 11918560
Serine protease inhibitor for treating coronavirus infection
granted patentUS 11919888
Neprilysin inhibitors
granted patentUS 11919901
Inhibitors of the menin-MLL interaction
granted patentUS 11919896
[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof
granted patentUS 11912786
Inhibitor of apoptosis protein (IAP) antagonists
granted patentUS 11912695
Benzodiazepine derivatives as RSV inhibitors
granted patentUS 11905285
Inhibitors of plasma kallikrein and uses thereof
granted patentUS 11897845
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
granted patentUS 11891389
PGDH inhibitors and methods of making and using
granted patentUS 11890281
SHP2 phosphatase inhibitors and methods of making and using the same
granted patentUS 11891399
Inhibitors of cancer invasion, attachment, and/or metastasis
granted patentUS 11891607
Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD
granted patentUS 11883381
ASH1L inhibitors and methods of treatment therewith
granted patentUS 11883386
Prolyl hydroxylase inhibitors and methods of use
granted patentUS 11884656
Pyrrole derivatives as PLK1 inhibitors
granted patentUS 11884657
PI-kinase inhibitors with anti-infective activity
granted patentUS 11884748
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bow
granted patentUS 11878977
JAK inhibitors containing a 4-membered heterocyclic amide
granted patentUS 11872261
Lipoprotein targeting protease inhibitors and uses
granted